No Data
No Data
Express News | VTv Therapeutics Inc - Net Loss Attributable to vTv Shareholders for Three Months Ended March 31, 2024, Was $4.9 Mln or $1.17 per Basic Share
Express News | VTv Therapeutics Q1 Operating Expenses USD 6.627 Million
Express News | VTv Therapeutics Q1 Operating Income USD -5.627 Million
vTv Therapeutics | 10-Q: Quarterly report
Express News | VTv Therapeutics Inc - Qtrly Revenue $1 Mln
Express News | VTv Therapeutics Inc - Qtrly Net Loss Attributable $1.17 per Basic Share
No Data